| Application no. and date | 05108494.5 (espacenet) (Federated) (European Patent Register), 20050915 | | Patent/reg. no. and date | DK/EP 1637167, 20140212 | | Publication date | 20060322 | | Priority no. and date | IT MI20041763, 20040916 | | EP pub. no. and date |
EP 1637167 20060322 | | Effective date | | | Applicant/owner | ALTERGON S.A., Via Dogana
Vecchia 2
CH-6903 Lugano, CH | | Applicant ref. no. | P14-049EDK | | Inventor | Zoppetti, Giorgio,
Via Mac Mahon, 43
20155, MILANO, IT,
Puppini, Nadia,
Via Muggiò, 42
22100, COMO, IT,
Pizzutti, Marco,
Via A. Costa, 8
21046, MALNATE, IT | | Representative | Patentgruppen A/S, Arosgården, Åboulevarden 31, 8000 Aarhus C | | Opponent | | | IPC Class | A61K 31/57 (2006.01) , A61K 47/48 (2006.01) | | Title | Injicerbare formuleringer indeholdende et kompleks mellem progesteron og hydroxypropyl-beta-cyclodextrin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
